• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤学中的苯并咪唑化学:合成、活性及构效关系分析的最新进展

Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis.

作者信息

Farag Basant, Zaki Magdi E A, Elsayed Doaa A, Gomha Sobhi M

机构信息

Department of Chemistry, Faculty of Science, Zagazig University Zagazig 44519 Egypt

Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia

出版信息

RSC Adv. 2025 Jun 3;15(23):18593-18647. doi: 10.1039/d5ra01077b. eCollection 2025 May 29.

DOI:10.1039/d5ra01077b
PMID:40463335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12132103/
Abstract

A six-membered benzene ring is fused with a five-membered imidazole ring at positions four and five, generating benzimidazole, the benzo derivative of imidazole and a bicyclic aromatic chemical compound. Benzimidazole is a significant pharmacophore in a variety of physiologically active heterocyclic compounds due to its distinctive characteristics and structural framework. Because benzimidazole is both aromatic and heterocyclic, it interacts with a range of biological targets metal ion interactions, π-π stacking, and hydrogen bonding. Its broad range of medicinal chemistry applications, such as anti-inflammatory, antiviral, antifungal, and anticancer therapies, is based on these interactions. Its significance in the development of potentially novel therapeutic pharmaceuticals is highlighted by the fact that its structural flexibility permits the synthesis of derivatives with targeted bioactivity. Derivatives of benzimidazole have garnered significant research interest as potential anticancer medications. These heterocyclic compounds exhibit a wide range of biological activities, such as DNA interaction, enzyme inhibition, and modulation of cellular pathways crucial to cancer development. Thus, to optimize their therapeutic potential, recent studies have focused on evaluating the structure-activity relationships (SAR) of benzimidazole derivatives. The main topics of this review are the current developments in the synthesis, anticancer activity, and SAR studies of benzimidazole derivatives, which will shed light on the increasing role they play in cancer therapies.

摘要

一个六元苯环在4位和5位与一个五元咪唑环稠合,生成苯并咪唑,它是咪唑的苯并衍生物,也是一种双环芳香化合物。由于其独特的特性和结构框架,苯并咪唑是多种生理活性杂环化合物中的重要药效基团。由于苯并咪唑既是芳香族又是杂环化合物,它与一系列生物靶点发生相互作用,包括金属离子相互作用、π-π堆积和氢键作用。其广泛的药物化学应用,如抗炎、抗病毒、抗真菌和抗癌治疗,都基于这些相互作用。其结构灵活性允许合成具有靶向生物活性的衍生物,这一事实凸显了其在开发潜在新型治疗药物方面的重要性。苯并咪唑衍生物作为潜在的抗癌药物已引起了大量研究兴趣。这些杂环化合物表现出广泛的生物活性,如DNA相互作用、酶抑制以及对癌症发展至关重要的细胞途径的调节。因此,为了优化其治疗潜力,最近的研究集中在评估苯并咪唑衍生物的构效关系(SAR)。本综述的主要主题是苯并咪唑衍生物在合成、抗癌活性和SAR研究方面的当前进展,这将揭示它们在癌症治疗中日益重要的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/4cb0853bf52f/d5ra01077b-s40.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/55ad310ea887/d5ra01077b-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/b6b8548ff2a9/d5ra01077b-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/89c9d1f61407/d5ra01077b-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/2e81c21a3c1c/d5ra01077b-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/c698c172cd86/d5ra01077b-s5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/d3cc81774843/d5ra01077b-s6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/acac0207b676/d5ra01077b-s7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/6f8fb0857caa/d5ra01077b-s8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/4af7965f4b71/d5ra01077b-s9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/369821a09518/d5ra01077b-s10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/358b2e2a634d/d5ra01077b-s11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/ea68609c7d1a/d5ra01077b-s12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/67f2233d7f26/d5ra01077b-s13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/122a6bf7681e/d5ra01077b-s14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/23966d8edd82/d5ra01077b-s15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/074079233858/d5ra01077b-s16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/c149e5195c65/d5ra01077b-s17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/c4e7556a7e10/d5ra01077b-s18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/3e3b9374ce22/d5ra01077b-s19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/2cf74c5b4656/d5ra01077b-s20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/13ba396b7840/d5ra01077b-s21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/15102e4bdb47/d5ra01077b-s22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/761212ddd2ac/d5ra01077b-s23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/866de99f59fb/d5ra01077b-s24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/bf79ca7d87e1/d5ra01077b-s25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/85693ec7ff50/d5ra01077b-s26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/e8b2163f7747/d5ra01077b-s27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/85b412b67b12/d5ra01077b-s28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/7271fbbba80f/d5ra01077b-s29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/ed8108e280c0/d5ra01077b-s31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/32a98d37be21/d5ra01077b-s32.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/bca0353cd32f/d5ra01077b-s34.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/9c016542ac2a/d5ra01077b-s35.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/33f6fae6f96a/d5ra01077b-s37.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/4cb0853bf52f/d5ra01077b-s40.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/55ad310ea887/d5ra01077b-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/b6b8548ff2a9/d5ra01077b-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/89c9d1f61407/d5ra01077b-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/2e81c21a3c1c/d5ra01077b-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/c698c172cd86/d5ra01077b-s5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/d3cc81774843/d5ra01077b-s6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/acac0207b676/d5ra01077b-s7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/6f8fb0857caa/d5ra01077b-s8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/4af7965f4b71/d5ra01077b-s9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/369821a09518/d5ra01077b-s10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/358b2e2a634d/d5ra01077b-s11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/ea68609c7d1a/d5ra01077b-s12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/67f2233d7f26/d5ra01077b-s13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/122a6bf7681e/d5ra01077b-s14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/23966d8edd82/d5ra01077b-s15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/074079233858/d5ra01077b-s16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/c149e5195c65/d5ra01077b-s17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/c4e7556a7e10/d5ra01077b-s18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/3e3b9374ce22/d5ra01077b-s19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/2cf74c5b4656/d5ra01077b-s20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/13ba396b7840/d5ra01077b-s21.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/15102e4bdb47/d5ra01077b-s22.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/761212ddd2ac/d5ra01077b-s23.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/866de99f59fb/d5ra01077b-s24.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/bf79ca7d87e1/d5ra01077b-s25.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/85693ec7ff50/d5ra01077b-s26.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/e8b2163f7747/d5ra01077b-s27.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/85b412b67b12/d5ra01077b-s28.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/7271fbbba80f/d5ra01077b-s29.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/ed8108e280c0/d5ra01077b-s31.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/32a98d37be21/d5ra01077b-s32.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/bca0353cd32f/d5ra01077b-s34.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/9c016542ac2a/d5ra01077b-s35.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/33f6fae6f96a/d5ra01077b-s37.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8869/12132103/4cb0853bf52f/d5ra01077b-s40.jpg

相似文献

1
Benzimidazole chemistry in oncology: recent developments in synthesis, activity, and SAR analysis.肿瘤学中的苯并咪唑化学:合成、活性及构效关系分析的最新进展
RSC Adv. 2025 Jun 3;15(23):18593-18647. doi: 10.1039/d5ra01077b. eCollection 2025 May 29.
2
An Outline on Benzimidazole Containing Marketed Drugs with Proton Pump Inhibitor and H Receptor Antagonist Activities.含苯并咪唑的已上市药物的概述,这些药物具有质子泵抑制剂和H受体拮抗剂活性。
Mini Rev Med Chem. 2025;25(6):440-462. doi: 10.2174/0113895575329633240928163509.
3
Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development.解锁苯并咪唑衍生物的药理潜力:药物开发之路。
Curr Top Med Chem. 2024;24(5):437-485. doi: 10.2174/0115680266283641240109080047.
4
Recent achievements in the synthesis of benzimidazole derivatives.苯并咪唑衍生物合成的近期成果。
RSC Adv. 2023 Nov 7;13(46):32734-32771. doi: 10.1039/d3ra05960j. eCollection 2023 Oct 31.
5
A Review on Modern Approaches to Benzimidazole Synthesis.苯并咪唑类化合物的现代合成方法研究进展
Curr Org Synth. 2023;20(6):595-605. doi: 10.2174/1570179420666221010091157.
6
The synthesis and characterization of Various metal complexes of 2-(4-nitrophenyl)-1H-benzimidazole and its mono schiff base precursor.2-(4-硝基苯基)-1H-苯并咪唑及其单席夫碱前体的各种金属配合物的合成与表征
Sci Prog. 2025 Jan-Mar;108(1):368504251323767. doi: 10.1177/00368504251323767. Epub 2025 Mar 16.
7
A Review of Approaches to the Metallic and Non-Metallic Synthesis of Benzimidazole (BnZ) and Their Derivatives for Biological Efficacy.苯并咪唑(BnZ)及其衍生物的金属和非金属合成方法及其生物功效研究综述。
Molecules. 2023 Jul 18;28(14):5490. doi: 10.3390/molecules28145490.
8
Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.苯并咪唑类骨架作为抗癌剂:合成方法与构效关系。
Arch Pharm (Weinheim). 2017 Jun;350(6). doi: 10.1002/ardp.201700040. Epub 2017 May 22.
9
Recent advances of benzimidazole as anticancer agents.苯并咪唑类化合物作为抗癌剂的最新进展。
Chem Biol Drug Des. 2023 Aug;102(2):357-376. doi: 10.1111/cbdd.14236. Epub 2023 Apr 3.
10
Antimicrobial potential of 1-benzo[]imidazole scaffold: a review.1-苯并咪唑支架的抗菌潜力:综述
BMC Chem. 2019 Feb 4;13(1):18. doi: 10.1186/s13065-019-0521-y. eCollection 2019 Dec.

引用本文的文献

1
Benzimidazole-Pyrimidine Hybrids: Synthesis and Medicinal Properties.苯并咪唑 - 嘧啶杂化物:合成与药用特性
Pharmaceuticals (Basel). 2025 Aug 19;18(8):1225. doi: 10.3390/ph18081225.

本文引用的文献

1
Bio-computational modeling, POM analysis and molecular dynamic simulation for novel synthetic quinolone and benzo[d][1,3]oxazine candidates as antimicrobial inhibitors.新型合成喹诺酮和苯并[d][1,3]恶嗪类抗菌抑制剂的生物计算建模、POM 分析和分子动力学模拟。
Sci Rep. 2024 Nov 20;14(1):28709. doi: 10.1038/s41598-024-73972-x.
2
Discovery of benzimidazole-2-amide BNZ-111 as new tubulin inhibitor.发现苯并咪唑-2-酰胺 BNZ-111 作为新的微管蛋白抑制剂。
Bioorg Med Chem Lett. 2024 Nov 15;113:129953. doi: 10.1016/j.bmcl.2024.129953. Epub 2024 Sep 11.
3
Benzimidazole-dioxoisoindoline conjugates as dual VEGFR-2 and FGFR-1 inhibitors: design, synthesis, biological investigation, molecular docking studies and ADME predictions.
作为双 VEGFR-2 和 FGFR-1 抑制剂的苯并咪唑 - 二氧代异吲哚啉共轭物:设计、合成、生物学研究、分子对接研究及 ADME 预测
RSC Adv. 2024 Sep 12;14(39):28889-28903. doi: 10.1039/d4ra05462h. eCollection 2024 Sep 4.
4
Synthesis of new two 1,2-disubstituted benzimidazole compounds: their in vitro anticancer and in silico molecular docking studies.新型两种1,2-二取代苯并咪唑化合物的合成:它们的体外抗癌及计算机模拟分子对接研究
BMC Chem. 2024 Aug 7;18(1):146. doi: 10.1186/s13065-024-01241-z.
5
Pharmacokinetic and molecular docking studies to pyrimidine drug using MnO nanoparticles to explore potential anti-Alzheimer activity.基于 MnO 纳米粒子的嘧啶类药物的药代动力学和分子对接研究,探索其潜在的抗阿尔茨海默病活性。
Sci Rep. 2024 Jul 4;14(1):15436. doi: 10.1038/s41598-024-65166-2.
6
Facile one-pot synthesis and in silico study of new heterocyclic scaffolds with 4-pyridyl moiety: Mechanistic insights and X-ray crystallographic elucidation.含4-吡啶基部分的新型杂环骨架的简便一锅法合成及计算机模拟研究:机理洞察与X射线晶体学解析
Heliyon. 2024 Apr 3;10(7):e29221. doi: 10.1016/j.heliyon.2024.e29221. eCollection 2024 Apr 15.
7
Synthesis of Bis-thiazoles Tethered 1,4-Dihydropyridine and Pyridine Linkers Simple Oxidation and their Molecular Docking as VEGFR -TK Inhibitors.双噻唑连接的1,4 - 二氢吡啶和吡啶连接基的合成、简单氧化及其作为VEGFR - TK抑制剂的分子对接
Curr Med Chem. 2025;32(9):1789-1802. doi: 10.2174/0109298673266044231002071238.
8
Chitosan-sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents.壳聚糖磺酸催化绿色合成萘基吖嗪作为潜在抗癌剂
Future Med Chem. 2024 Apr;16(7):647-663. doi: 10.4155/fmc-2023-0351. Epub 2024 Feb 22.
9
Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV.查尔酮/1,3,4-恶二唑/苯并咪唑杂化物作为新型抗增殖剂诱导细胞凋亡并抑制表皮生长因子受体(EGFR)和B-Raf原癌基因丝氨酸/苏氨酸蛋白激酶(BRAFV)
BMC Chem. 2023 Sep 16;17(1):116. doi: 10.1186/s13065-023-01003-3.
10
Mechanochemical Synthesis and Molecular Docking Studies of New Azines Bearing Indole as Anticancer Agents.新型含吲哚偶氮类化合物的机械化学合成及分子对接研究及其作为抗癌药物。
Molecules. 2023 May 4;28(9):3869. doi: 10.3390/molecules28093869.